The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Ivanets T.Iu.

FGBU "Nauchnyĭ tsentr akusherstva, ginekologii i perinatologii im. akad. V.I. Kulakova" Minzdravsotsrazvitiia Rossii, Moskva

Alekseeva M.L.

FGBU "Nauchnyĭ tsentr akusherstva, ginekologii i perinatologii im. akad. V.I. Kulakova" Minzdravsotsrazvitiia Rossii, Moskva

Kolod'ko V.G.

FGBU "Nauchnyĭ tsentr akusherstva, ginekologii i perinatologii im. akad. V.I. Kulakova" Minzdrava Rossii, Moskva

DIAGNOSTIC VALUE OF ALFA-FETOPROTEIN IN ONCOLOGY, PERINATOLOGY AND NEONATOLOGY (A REVIEW)

Authors:

Ivanets T.Iu., Alekseeva M.L., Kolod'ko V.G.

More about the authors

Journal: Russian Journal of Human Reproduction. 2012;(6): 14‑19

Read: 24267 times

Download PDF (RU)
Contact the author
Table of contents

DIAGNOSTIC VALUE OF ALFA-FETOPROTEIN IN ONCOLOGY, PERINATOLOGY AND NEONATOLOGY (A REVIEW)
DIAGNOSTIC VALUE OF ALFA-FETOPROTEIN IN ONCOLOGY, PERINATOLOGY AND NEONATOLOGY (A REVIEW)

To cite this article:

Ivanets TIu, Alekseeva ML, Kolod'ko VG. DIAGNOSTIC VALUE OF ALFA-FETOPROTEIN IN ONCOLOGY, PERINATOLOGY AND NEONATOLOGY (A REVIEW). Russian Journal of Human Reproduction. 2012;(6):14‑19. (In Russ.)

 
Подписка 2026 Проблемы репродукции (Russian Journal of Human Reproduction)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Primary outcomes after major anatomical liver rese­ctions in infa­nts at the National Children’s Medi­cal Center. Piro­gov Russian Journal of Surgery. 2025;(4):86-94
Approaches to the digi­tization of clinical guidelines. Medi­cal Technologies. Asse­ssment and Choice. 2025;(2):39-47
Dyna­mics of the main indi­cators of medi­cal care to the popu­lation of the Russian Fede­ration for the period 1993—2023 in the “Oncology” profile. P.A. Herzen Journal of Onco­logy. 2025;(3):71-77
New analgesics in onco­logy. Tafa­lgin employed as an alte­rnative to opioid analgesics. P.A. Herzen Journal of Onco­logy. 2025;(5):73-77
A clinical case of osteonecrosis of the jaw in an onco­logy patient that occu­rred after periodontal surgery. Russian Journal of Stomatology. 2025;(4):75-79
Effi­cacy and safety of Russian-made peri­pherally inse­rted central catheters in premature infa­nts: a randomized clinical trial. Russian Journal of Anesthesiology and Reanimatology. 2025;(6):58-67
The role of outpatient clinics in the timely dete­ction of an onco­logical pathology in pregnant women. Russian Journal of Preventive Medi­cine. 2025;(12):31-34
Modern trends in the opti­mization of onco­logical education. P.A. Herzen Journal of Onco­logy. 2026;(1):37-42
Robot-assisted multivisceral rese­ctions for loca­lly adva­nced rectal cancer: a case series and systematic review. Piro­gov Russian Journal of Surgery. 2026;(2):14-22
Diagnosis-related groups in the treatment of lung cancer: stru­ctural analysis of medi­cal care in a 24-hour inpa­tient setting. Medi­cal Technologies. Asse­ssment and Choice. 2026;(1):26-35
Abstract:

The information concerning alfafetoprotein structure and function is presented, as well as informative value of this marker concentration in oncology, obstetrics, neonatology and perinatology is summarizes.

Keywords:

alpha-fetoprotein
perinatology
neonatology
oncology

Authors:

Ivanets T.Iu.

FGBU "Nauchnyĭ tsentr akusherstva, ginekologii i perinatologii im. akad. V.I. Kulakova" Minzdravsotsrazvitiia Rossii, Moskva

Alekseeva M.L.

FGBU "Nauchnyĭ tsentr akusherstva, ginekologii i perinatologii im. akad. V.I. Kulakova" Minzdravsotsrazvitiia Rossii, Moskva

Kolod'ko V.G.

FGBU "Nauchnyĭ tsentr akusherstva, ginekologii i perinatologii im. akad. V.I. Kulakova" Minzdrava Rossii, Moskva

Close metadata

References:

  1. Alekseeva M.L. AFP. Ispol'zovanie v onkologii i perinatologii. Probl reprod 2000; 3: 13-19.
  2. Alekseeva M.L., Pustotina O.A., Fanchenko N.D., Pankratova T.S. AFP kak prognosticheskii pokazatel' sostoyaniya novorozhdennogo. Probl reprod 2005; 5: 10-15.
  3. Bakharev V.A., Karetnikova V.A., Alekseeva M.L., Kolod'ko V.G., Stygar A.M. Informativnost' skriningovykh programm v diagnostike patologii ploda. Akush i ginekol 2008; 6: 29-33.
  4. Ekimova E.V., Alekseeva M.L., Kolod'ko V.G., Ivanets T.Yu., Pustotina O.A. Al'fa-fetoprotein i Β2-mikroglobulin kak prognosticheskie pokazateli sostoyaniya novorozhdennykh. Probl reprod 2010; 2: 97-101.
  5. Ivanets T.Yu., Alekseeva M.L., Ekimov A.N., Ekimova E.V., Kolod'ko V.G., Pankratova T.S. Nekotorye biologicheskie markery v akusherstve, perinatologii i neonatologii. Probl reprod 2011; 3: 97-101.
  6. Abelev G.I. Alpha-fetoprotein in ontogenesis and its association with malignant tumors. Advanc Cancer Res 1971; 14: 295-358.
  7. Abelev G.I. Alpha-fetoprotein as a marker of embryo-specific differentiation's in normal and tumor tissues. Transplantation 1974; 20: 3-37.
  8. Abelev G.I. Alpha-fetoprotein: the genesis. Oncodevelopmental Biol Med 1983; 4: 371-381.
  9. Abelev G.I. Antigenic structure of cemistry-induced hepatomas. Progr Exp Tumor Res 1965; 7: 104-157.
  10. Abelev G.I. Study of the regulation of alpha-fetoprotein synthesis in ontogenesis and carcinogenesis. Sov Sci Rev Sect D Biol Rev (New York) 1980; l: 371-397.
  11. Abelev G.I., Perova S., Khramkova N.I. et al. Production of embryonal alpha-globulin by the transplantable mouse hepatomas. Transplantation 1963; 5: 174-180.
  12. Aitken D.A., Crossley J.A. Neural tube defects/ alpha-fetoprotein/Down's syndrome screening. Curr Opin Obstet Gynecol 1997; 9-2: 113-120.
  13. Alembik Y., Dott V., Roth M.P., Stoll S. Prevalence of neural tube defects in northeastern France, 1979-1992 impact of prenatal diagnosis. Ann Genet 1995; 38-1: 49-53.
  14. Arends J. et al. Prenatal screening for neural-tube defects, quality specification of maternal serum alpha-fetoprotein analysis. Ups J Med Sci 1993; 98-3: 339-347.
  15. Barnabei V.M., Krantz D.A., Macri J.N., Larsen J.M. Enhanced twin pregnancy detection within an open neural tube defect and Down syndrome screening protocol using free-beta hcg and AFP. Prenat Diagn 1995; l5-12: 1131-1134.
  16. Bergstrand C.G., Craz B. Demonstration of a new protein fraction in serum from the human fetus. Scand J Din Lab Invest 1956; 8: 174-179.
  17. Brock D.G.H., Bolton A.T. Prenatal diagnosis of anencephaly through maternal serum alpha-fetoprotein. Scand J Din Lab Invest 1973; 2: 923-924.
  18. Chen C.P., Chern S.R., Liu F.F. et al. Prenatal diagnosis of a deletion of 18q in a fetus associated with multiple-marker screen positive results. Prenat Diagn 1997; 17-6: 571-576.
  19. Clarke P.C., Gordon Y.B., Kitau M.J. et al. Alpha-fetoprotein levels in pregnancies complicated by gastrointestinal abnormalities of the fetus. Br J Obstet Gynec 1977; 84-4: 285-289.
  20. Cohen V., Graham H., Lorrin Lau H. Alpha-1 fetoprotein in pregnancy. Am J Obstet Gynec 1973; l5-7: 881-883.
  21. Cuckle H., Densem J., Wald N. Repeat maternal serum testing in multiple marker Down's syndrome screening programmes. Prenat Diagn 1994; 14-7: 603-607.
  22. Dick P.T. Periodic health examination, 1996 update: 1. Prenatal screening for and diagnosis of Down syndrome. Canadian Task Force on the Periodic Health Examination. Can Med Ass J 1996; 54-4: 465-479.
  23. Edeling C.I., Schioler V., Thisted I. Alpha-fetoprotein in cord serum correlated togestationae age. Acta Obstet Gynec Scand 1977; 56-1: 15-17.
  24. Fourth Report of the UK collaborative study on AFP in relation to neural-tube defects. Estimating an individual's risk of having a fetus with open spina bifida and the value of repeat AFP-testing. J Epid Comm Hith 1982; 36: 87-95.
  25. Gaspard U.Y., Reuter A.M., Delive Y.L. Trophoblastic tumors. Clin Endocr 1998; 13: 319-329.
  26. Gibbs P., Zielinski R., Boyd C., Dugaiczyk A. Structure, polymorphism, and novel repeated DNA elements revealed by a complete sequence of human alpha-fetoprotein gene. Biochemistry 1987; 26: 1332-1343.
  27. Gitlin D., Pericelli A. Giti in G. Synthesis of alpha-fetoprotein by liver, yolk sac and gastrointestinal tract of the human concepts. Cancer Res 1972; 32: 979-982.
  28. Guertin M., La Rue H., Bemier D. et al. Enhancer and promoter elements directing activation and glucocorticoid repression of the alpha-fetoprotein gene in hepatocytes. Mol Cell Biol 1988; 8: 1398-1407.
  29. Harper M.E., Dugaiczyk A. Linkage of the evolutionary related serum albumin and alpha-fetoprotein genes within ql 1-22 of human chromosome 4. Am J Hum Genet 1994; 35: 565-572.
  30. Masopust J., Kithier R., Radi I. et al. Occurrence of fetoprotein in patients with neoplasms and non-neoplastic disease. Int J Cancer 1967; 2: 551-558.
  31. Masseyeff R. Human alpha-fetoprotein (review). Path Biol 1972; 20: 703-727.
  32. Mikulikova L., Struplova J., Fialova L., Malbohan I. Disorders of fetoplacental function in pregnant women with diabetes. Sb Lek 1993; 94-2: 173-177.
  33. Morssink L.P., Sikkema-Raddatz V., Beekhuis J.R. et al. Placental mosaicism is associated with unexplained second-trimester elevation of MSHCG levels, but not with elevation of MSAFP levels. Prenat Diagn 1996; 16-9: 845-851.
  34. Nunez E., Benassayag C., Grysteff N. et al. Estrogen and fatty acid binding properties of murine AFP: a guide to explain some biological activities of this protein. Eds G. Mizejewski, H. Jacobson. Biol Activ Alpha-Fetoprotein 1987; 1: 3-18.
  35. Petry M. Elevation of maternal alpha-fetoprotein in systemic lupus erythematosus: a controlled study. J Reumatol 1995; 22-7: 1365-1368.
  36. Piggott M., Wilkinson P., Bennett J. Impelementation of an antenatal serum screening programme for Down's syndrome in two districts (Brighton and Eastbourne). The Brighton and Eastbourne Down's Syndrome Screening Group. J Med Screen 1994; 1-1: 45-49.
  37. Ruoslahti E., Seppala M. Alpha-fetoprotein in cancer and fetal development. Advanc Cancer Res 1979; 29: 275-346.
  38. Schittger A., Liedgren S., Reedberg S. et al. Raised maternal serum and amniotic fluid alpha-fetoprotein levels associated with a placental haemangioma. Case report. Br J Obstet Gynec 1980; 87-9: 824-826.
  39. Smith C., Kelleher Ph. Biological Activities of Alpha-Fetoprotein. Eds G. Mizejeweski, H. Jacobson 1989; 2: 35-43.
  40. Takayma H. A case of bladder cancer producing alpha-fetoprotein (AFP). Hinyokika Kyio 1995; 41-5: 387-389.
  41. Taketa K. Alpha-fetoprotein: reevaluation in gepatology. Hepatology 1990; 12-6: 1420-1432.
  42. Tatarinov Y.S. Presence ofembryonal alpha-globulin in the serum of patient with primary hepatocellular carcinoma. Vopr Med Chirmi 1964; 10: 90-91.
  43. Toftager-Larsen K., Benzie R.I., Doran T.A. et al. Alpha-fetoprotein and ultrasound scanning in the prenatal diagnosis of Terner's syndrome. Prenat Diagn 1983; 3-1: 35-40.
  44. Wald N.J., Densem J.W., Smith D., Klee G.G. Four-marker serum screening for Down's syndrome. Prenat Diagn 1994; 14-8: 707-716.
  45. Waller D.K., Lustig L.S., Cunningham G.C. et al. The association between maternal serum alpha-fetoprotein and preterm birth, small for gestational age infants, preeclampsia, and placental complications. Obstet Gynecol 1996; 88-5: 816-822.
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.